Obesity experts advise on new treatments
Source: PHARMAC With high obesity rates in New Zealand and new medicines entering the market, public interest in weight‑loss treatments is understandably strong. In June 2025 Medsafe approved semaglutide (Wegovy) for use in New Zealand for weight loss. Medsafe approves medicines for use in New Zealand. They check that these products meet our standards for … Read more